Harold C. Simmons Cancer Center Tissue Management Shared Resource (Translational Research Resource) Project Summary/Abstract The Tissue Management Shared Resource was established in 2004 to provide IRB-approved centralized tissue procurement services for specimens derived from consented human participants. Over 22,000 tissue specimens and bodily fluids, from over 50 different tissue types including breast, lung, prostate, kidney, bladder, colon, pancreas, blood, pleural fluid, urine and bone marrow have been collected since its establishment. In terms of demographics, specimens were obtained from Caucasian (72%), African-American (24%) and Hispanic participants (16%). Of the tissues collected, 56% of specimens are derived from female participants. Although the basic functions and goals of the Tissue Management Shared Resource remain essentially unchanged, the capabilities of the facility have been significantly expanded to support the growing needs of Simmons Cancer Center members and facilitate translational research activities. To facilitate this growth, Tissue Management Shared Resource has moved to a new location that provides additional space for equipment and staff. The equipment has been updated to accommodate increased and changing research needs. Additionally, tissue banking and annotation of specimens has been extensively expanded. Specimen related data are captured and stored in our tissue management database, caTissue Plus, and are correlated with clinical information through the Simmons Cancer Center's clinical research data warehouse (i2b2) as part of the UTSW Center for Translational Medicine (CTM), which is the institutional CTSA (Clinical & Translational Science Award). This tool links caTissue Plus data with EPIC Clarity (the electronic medical record), Oncolog (the university tumor registry database), CoPath (the anatomical pathology database), CancerGeneConnect (the familial genetics database) and other disease-specific databases. Due to this robust infrastructure, biospecimens are automatically annotated with demographic, pathological, and clinical data so that interested investigators can perform basic sample availability queries of this database in a de-identified manner through a secure web interface.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA142543-10S3
Application #
10260741
Study Section
Subcommittee I - Transistion to Independence (NCI)
Program Officer
Belin, Precilla L
Project Start
2010-08-03
Project End
2021-07-31
Budget Start
2019-08-01
Budget End
2020-07-31
Support Year
10
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Type
DUNS #
800771545
City
Dallas
State
TX
Country
United States
Zip Code
75390
Li, Xiangyi; Baek, GuemHee; Ramanand, Susmita G et al. (2018) BRD4 Promotes DNA Repair and Mediates the Formation of TMPRSS2-ERG Gene Rearrangements in Prostate Cancer. Cell Rep 22:796-808
Balasubramanian, Bijal A; Jetelina, Katelyn K; Bowen, Michael et al. (2018) Surveillance for colorectal cancer survivors in an integrated safety-net health system in the United States. Int J Care Coord 21:26-35
Li, Ran; Chiguru, Srinivas; Li, Li et al. (2018) Targeting Phosphatidylserine with Calcium-Dependent Protein-Drug Conjugates for the Treatment of Cancer. Mol Cancer Ther 17:169-182
Wijayatunge, Ranjula; Holmstrom, Sam R; Foley, Samantha B et al. (2018) Deficiency of the Endocytic Protein Hip1 Leads to Decreased Gdpd3 Expression, Low Phosphocholine, and Kypholordosis. Mol Cell Biol 38:
Rashdan, Sawsan; Minna, John D; Gerber, David E (2018) Diagnosis and management of pulmonary toxicity associated with cancer immunotherapy. Lancet Respir Med 6:472-478
Miyata, Naoteru; Morris, Lindsey L; Chen, Qing et al. (2018) Microbial Sensing by Intestinal Myeloid Cells Controls Carcinogenesis and Epithelial Differentiation. Cell Rep 24:2342-2355
Hamann, Heidi A; Shen, Megan J; Thomas, Anna J et al. (2018) Development and Preliminary Psychometric Evaluation of a Patient-Reported Outcome Measure for Lung Cancer Stigma: The Lung Cancer Stigma Inventory (LCSI). Stigma Health 3:195-203
Murphy, Caitlin C; Singal, Amit G; Baron, John A et al. (2018) Decrease in Incidence of Young-Onset Colorectal Cancer Before Recent Increase. Gastroenterology 155:1716-1719.e4
Mokdad, Ali A; Xie, Xian-Jin; Zhu, Hong et al. (2018) Statistical justification of expansion cohorts in phase 1 cancer trials. Cancer 124:3339-3345
Murphy, Caitlin C; Fullington, Hannah M; Alvarez, Carlos A et al. (2018) Polypharmacy and patterns of prescription medication use among cancer survivors. Cancer 124:2850-2857

Showing the most recent 10 out of 501 publications